Trials / Completed
CompletedNCT01899573
Percutaneous Left Ventricular Reshaping to Reduce Functional Mitral Regurgitation and Improve LV Function
A Study of Percutaneous Left Ventricular Reshaping of Mitral Apparatus to Reduce Functional Mitral Regurgitation and Improve LV Function Using the Accucinch® System
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Ancora Heart, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is designed to demonstrate the safety, feasibility and potential efficacy of using the AccuCinch® System to reduce functional mitral regurgitation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AccuCinch® Ventriculoplasty System | Percutaneous intervention for the treatment of functional mitral regurgitation |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2016-01-01
- Completion
- 2016-03-01
- First posted
- 2013-07-15
- Last updated
- 2017-06-08
Locations
1 site across 1 country: Colombia
Source: ClinicalTrials.gov record NCT01899573. Inclusion in this directory is not an endorsement.